These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 12918580)

  • 1. Thrombogenicity is not reduced when heparin and phospholipid bonded circuits are used in a rabbit model of extracorporeal circulation.
    Meinhardt JP; Annich GM; Miskulin J; Kawai T; Ashton BA; Bartlett RH
    ASAIO J; 2003; 49(4):395-400. PubMed ID: 12918580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers.
    Annich GM; Meinhardt JP; Mowery KA; Ashton BA; Merz SI; Hirschl RB; Meyerhoff ME; Bartlett RH
    Crit Care Med; 2000 Apr; 28(4):915-20. PubMed ID: 10809259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing a small animal model of extracorporeal circulation.
    Skrzypchak AM; Miskulin J; Bartlett RH; Annich GM
    ASAIO J; 2006; 52(3):296-302. PubMed ID: 16760719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of varying nitric oxide release to prevent platelet consumption and preserve platelet function in an in vivo model of extracorporeal circulation.
    Skrzypchak AM; Lafayette NG; Bartlett RH; Zhou Z; Frost MC; Meyerhoff ME; Reynolds MM; Annich GM
    Perfusion; 2007 May; 22(3):193-200. PubMed ID: 18018399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of blood flow rate on thrombogenesis in a rabbit extracorporeal circulation model.
    Kawai T; Annich GM; Meinhardt JP; Ichiba S; Brant DO; Bartlett RH
    ASAIO J; 1999; 45(5):478-81. PubMed ID: 10503629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the additional use of heparin-coated extracorporeal circuits (ECC) optimize the effect of modified ultrafiltration (MUF) in pediatric perfusion?
    Harig F; Meier C; Hakami L; Strasser R; Bretzger J; Münch F; Vestweber-Wilmes E; Singer H; Weyand M; Cesnjevar R
    Thorac Cardiovasc Surg; 2006 Apr; 54(3):168-72. PubMed ID: 16639677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a new heparin-coated dense membrane lung with nonheparin-coated dense membrane lung for prolonged extracorporeal lung assist in goats.
    Ichinose K; Okamoto T; Tanimoto H; Yoshitake A; Tashiro M; Sakanashi Y; Kuwana K; Tahara K; Kamiya M; Terasaki H
    Artif Organs; 2004 Nov; 28(11):993-1001. PubMed ID: 15504115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
    Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
    J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AN69 ST haemodialysis membrane under conditions of two different extracorporeal circuit rinse protocols a comparison of thrombogenicity parameters.
    Richtrova P; Opatrny K; Vit L; Sefrna F; Perlik R
    Nephrol Dial Transplant; 2007 Oct; 22(10):2978-84. PubMed ID: 17597089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo testing of heparin-coated extracorporeal circuits: bovine experiments.
    Weerwind PW; van der Veen FH; Lindhout T; de Jong DS; Cahalan PT
    Int J Artif Organs; 1998 May; 21(5):291-8. PubMed ID: 9684912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An N-substituted polyurea coating with high affinity for heparin.
    Nemets EA; Karelskaya E; Sevastianov VI; Anderson JM; Harasaki H; Kim SW
    ASAIO J; 1993; 39(3):M319-21. PubMed ID: 8268551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal membrane oxygenation without anticoagulation: a study using quantitative scanning electron microscopy.
    Kundu SK; Salley SO; Whittlesey GC; Klein MD
    J Lab Clin Med; 1989 Jul; 114(1):58-62. PubMed ID: 2738449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin in lieu of anticoagulation with heparin for extracorporeal circulation.
    Addonizio VP; Fisher CA; Bowen JC; Palatianos GC; Colman RW; Edmunds LH
    Trans Am Soc Artif Intern Organs; 1981; 27():304-7. PubMed ID: 7036500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation.
    Straub A; Wendel HP; Dietz K; Schiebold D; Peter K; Schoenwaelder SM; Ziemer G
    Thromb Haemost; 2008 Mar; 99(3):609-15. PubMed ID: 18327411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PMEA polymer-coated PVC tubing maintains anti-thrombogenic properties during in vitro whole blood circulation.
    Yoshizaki T; Tabuchi N; van Oeveren W; Shibamiya A; Koyama T; Sunamori M
    Int J Artif Organs; 2005 Aug; 28(8):834-40. PubMed ID: 16211534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocompatibility of extracorporeal circulation. In vitro comparison of heparin-coated and uncoated oxygenator circuits.
    Videm V; Mollnes TE; Garred P; Svennevig JL
    J Thorac Cardiovasc Surg; 1991 Apr; 101(4):654-60. PubMed ID: 2008104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen adsorption, platelet adhesion and thrombin generation at heparinized surfaces exposed to flowing blood.
    Keuren JF; Wielders SJ; Willems GM; Morra M; Lindhout T
    Thromb Haemost; 2002 Apr; 87(4):742-7. PubMed ID: 12008960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of the Combined Argatroban/Nitric Oxide-Releasing Polymer on Platelet Microparticle-Induced Thrombogenicity in Coated Extracorporeal Circuits.
    Bellomo TR; Jeakle MA; Meyerhoff ME; Bartlett RH; Major TC
    ASAIO J; 2021 May; 67(5):573-582. PubMed ID: 33902103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of blood components exposed to coated arterial filters in extracorporeal circuits.
    Hussaini BE; Treanor PR; Healey NA; Tilahun D; Srey R; Lu XG; Khuri SF; Thatte HS
    Perfusion; 2009 Sep; 24(5):317-23. PubMed ID: 19965951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.